MedCity Pivot

Arundhati interviewed Dr. Erich Huang, Chief Data Officer for Quality at Duke Health, and the Director of Duke Forge. They talk about why more hospitals are implementing machine learning tools for healthcare, and the challenges of ensuring these models do not yield biased results. Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ Connect with Dr. Erich Huang https://forge.duke.edu/erich-s-huang-md-phd https://www.linkedin.com/in/erichhuang/ 

Arundhati interviewed Glen Tullman to talk about his new venture and how he wants to transform the employee benefits and care navigation market. Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ 

Arundhati interviewed Ho Cho, senior vice president of Discovery Biotherapeutics at BMS talking about drug discovery and the interesting therapies that BMS is developing to treat myeloma and lupus. Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ Connect with Ho Cho https://www.linkedin.com/in/ho-cho-9173162/ 

Arundhati interviews Sean Slovenski, CEO of BioiQ, and they talk about how Covid-19 has affected the world of diagnostics and at-home testing. Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ Connect with Sean Slovenski sslovenski@bioiq.com tj@thinkrevivehealth.com 

Arundhati interviewed Dr. Ami Bhatt, a cardiologist with Mass General Brigham, about the value of virtual care. Dr. Ami Bhatt specializes in lifelong care and empowerment of Teens and Adults with Congenital Heart Disease. He addresses valve problems, heart failure, multidisciplinary surgery, arrhythmia, pregnancy, transition, telemedicine & wellness programs.   Dr. Bhatt is an active clinical cardiologist, clinical investigator, and educator. She graduated from Harvard University, obtained her doctoral degree from Yale School of Medicine, and then trained at BWH. She works at the Children's Hospital of Boston and Mass General in internal medicine, pediatrics, cardiology, and adult congenital heart disease (ACHD).   Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com  https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ Connect with Dr. Ami Bhatt abhatt@mgh.harvard.edu

Arundhati interviewed Sree Chaguturu, chief medical officer of CVS Caremark and they discussed Covid-19 testing and vaccine distribution among other things.   Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com  https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ Connect with Sree Chaguturu https://twitter.com/chaguturu?lang=en  https://www.linkedin.com/in/sreekanth-chaguturu-9929ab4 

Arundhati interviewed Daniel Levner, co-founder of Sight Diagnostics, to talk about how machine learning can transform the field of complete blood count testing.   Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com  https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ Connect with Daniel Levner https://www.sightdx.com/international  https://www.linkedin.com/company/sight-diagnostics/  levner@sightdx.com  judy@sightdx.com

Arundhati interviewed Mark Bertolini, the former CEO and Chairman of Aetna, about the future of health insurance.   Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com  https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ Connect with Mark Bertolini mark@anahata.org https://www.linkedin.com/in/markbertolini

AstraZeneca US Head of Medical Affairs Oncology Camille Hertzka shares the pharma company's most recent lung cancer treatment study findings and insights on the changing landscape of lung cancer treatment driven by precision medicine.   Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com  https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ Connect with Camille Hertzka  camille.hertzka@astrazeneca.com

Arundhati interviewed Carolyn Magill, CEO of Aetion. They discussed the growing importance of real-world evidence in getting drugs approved and reimbursed.   Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com  https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ Connect with Carolyn Magill carolyn.magill@aetion.com https://www.aetion.com/leadership/carolyn-magill